Differential responses of estrogen target tissues in rats including bone to clomiphene, enclomiphene, and zuclomiphene

Endocrinology

Volumn 139, Issue 9, 1998, Pages 3712-3720

  Turner, Russell T ^a,d   Evans, Glenda L ^a   Sluka, James P ^b   Adrian, M D ^b   Bryant, Henry U ^b   Turner, Charles H ^c   Sato, Masahiko ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1,2 TRIPHENYLETHYLENE DERIVATIVE; CLOMIFENE; ENCLOMIFENE; RALOXIFENE; TAMOXIFEN; ZUCLOMIFENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE STRENGTH; CHOLESTEROL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FEMALE; HORMONE RESPONSE; NONHUMAN; OSTEOPENIA; OVARIECTOMY; PRIORITY JOURNAL; RAT; TARGET CELL; UTERUS WEIGHT;

EID: 0031788304     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.9.6177     Document Type: Article

References (36)

1. Massai MR, deZiegler D, Lesobre V, Bergeron C, Frydman R, Bouchard P 1993 Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment. Fertil Steril 59:1179-1186
2. Jordan VC 1984 Biochemical pharmacology of antiestrogen action. Pharmacol Rev 36:245-269
3. Lerner LJ, Jordan VS 1990 Development of antiestrogens and their use in breast cancer: Eight Cain Memorial Award Lecture. Cancer Res 50:4177-4189
4. Katzenellenbogen BS, Miller MA, Mullick A, Sheen YY 1985 Antiestrogens: action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites. Breast Cancer Res Treat 5:231-243
5. Turner RT, Wakley GK, Hannon KS 1987 Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats. J Bone Miner Res 2:449-456
6. Black LJ, Jones CD, Falcone JF 1983 Antagonism of estrogen action with a new benzothiophene derived anti-estrogen. Life 32:1031-1036
7. Jordan VC, Phelps E, Lindgren JV 1987 Effects of antiestrogens on bone in castrated and intact female rats. Breast Cancer Res Treat 10:31-35
8. Moon LY, Wakley GK, Turner RT 1991 Dose-dependent effects of tamoxifen on long bones in growing rats: influence of ovarian status. Endocrinology 129:1568-1574
9. Black LJ, Sato M, Rowley ER, Magee DE, Bekele A, Williams DC, Cullinan GJ, Bendele R, Kauffman RF, Bensch WR, Frolik CA, Termine JO, Bryant HU 1994 Raloxifene (LY139481 HCL) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 93:63-69
10. Chakraborty PK, Brown JL, Ruff CV, Nelson MF, Mitchell AS 1991 Effects of long term treatment with estradiol or clomiphene citrate on bone maintenance, and pituitary and uterine weights in ovariectomized rats. J Steroid Biochem Mol Biol 40:725-729
11. Jimenez MA, Magee DE, Bryant HU, Turner RT 1997 Clomiphene prevents cancellous bone loss from tibia of ovariectomized rats. Endocrinology 138:1794-1800
12. Evans G, Bryant HU, Magee DE, Sato M, Turner RT 1994 The effects of raloxifene on tibia histomorphometry in ovariectomized rats. Endocrinology 134:2283-2288
13. Hutchinson TA, Polansky SM, Feinsstein AR 1979 Postmenopausal oestrogens protect against fractures of hip and distal radius. Lancet 2:705-709
14. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR 1992 Hormone therapy to prevent disease and prolong life in postmenopausal Women. Ann Intern Med 117:1016-1037
15. Mack TM, Ross RK 1989 Risks and benefits of long term treatment with estrogens. Schweiz Med Wochenschr 119:1811-1820
16. Henderson BE 1989 The cancer question: an overview of recent epidemiologic and retrospective data. Am J Obstet Gynecol 161:1859-1864
17. Jordan VC, Phelps E, Lindgren JV 1987 Effects of antiestrogens on bone in castrated and intact female rats. Breast Cancer Res Treat 10:31-35
18. Beall PT, Misra LK, Young RL, Spjut HJ, Evans HJ, LeBlanc A 1984 Clomiphene prevents against osteoporosis in the mature ovariectomized rats. Calcif Tissue Int 36:123-125
19. Sato M, Rippy MK, Bryant HU 1996 Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats. FASEB J 10:905-912
20. Sibonga JD, Evans GL, Hauck ER, Bell NH, Turner RT 1996 Ovarian status influences the skeletal effects of tamoxifen in adult rats. Breast Cancer Res Treat 41:71-79
21. Bryant HU, Glasebrook AL, Yang NN, Sato M 1996 A pharmacological review of raloxifene. J Bone Miner Metab 14:1-9
22. Kauffman RF, Bryant HU 1995 Selective estrogen receptor modulators. Drug News Perspect 8:531-539
23. Young RL, Goldzieher JW, Chakraborty PK, Panko WB, Bridges CN 1991 Qualitative differences in estrogenic/antiestrogenic effects of clomiphene and zuclomiphene. Int J Fertil 36:291-295
24. Burghardt RC, Gaddy-Kurten D, Burghardt RL, Kurten RC, Mitchell PA 1987 Gap junction modulation in rat uterus. III. Structure-activity relationships of estrogen receptor-binding ligands on myometrial and serosal cells. Biol Reprod 36:741-751
25. Lyttle CR, DeSombren ER 1977 Uterine peroxidase as a marker for estrogen action. Proc Natl Acad Sci USA 74:3162-3166
26. White SR, Kulp VP, Spaethe SM, VanAlstyne EL, Leff AR 1991 A kinetic assay for eosinophil peroxidase activity in eosinophils and eosinophil conditioned media. J Immunol Methods 44:257-263
27. Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS 1983 Relationships between surface, volume and thickness of iliac trabecular bone in aging and osteoporosis: implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72:1396-1409
28. Shen V, Dempster DW, Birchman R, Xu R, Lindsay R 1993 Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J Clin Invest 91:2479-2487
29. Turner CH, Burr DB 1993 Basic biomechanical measurements of bone: a tutorial. Bone 14:595-608
30. Keller TS, Spengler DM, Carter DR 1986 Geometric, elastic, and structural properties of maturing rat femora. J Orthop Res 4:57-67
31. Turner RT, Vandersteenhoven JJ, Bell NH 1990 The effects of ovariectomy and 17β-estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res 2:115-122
32. Wronski TJ, Lowry PL, Walsh CC, Ignaszewski LA 1985 Skeletal alterations in ovariectomized rats. Calcif Tissue Int 37:324-328
33. Wronski TJ, Cintron M, Doherty AL, Dann LM 1988 Estrogen treatment prevents osteopenia and depressed bone turnover in ovariectomized rats. Endocrinology 123:681-686
34. Shen V, Dempster DW, Mellish RWE, Birchman R, Horbert W, Lindsay R 1992 Effects of combined and separate intermittent administration of low dose human parathyroid hormone fragment (1-34) and 17β-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia. Calcif Tissue Int 50:214-220
35. Westerlind KC, Wronski TJ, Ritman EL, Luo Z-P, An K-N, Bell NH, Turner RT 1997 Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain. Proc Natl Acad Sci USA 94:4199-4204
36. Delmas PD, Garnero P 1996 Utility of biochemical markers of bone turnover in osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, New York, pp 1075-1088